- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
前期的强势行情已经结束，投资者及时卖出股票为为宜。
- 中期趋势：
下跌有所减缓，仍应保持谨慎。
- 长期趋势：
已有40家主力机构披露2025-06-30报告期持股数据，持仓量总计7846.90万股，占流通A股29.60%
- 波段诊断：
-
技术面诊股
诊断结果：4.4技术面打败了19%的股票
技术面评分前10的股票
近期的平均成本为15.39元。空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
平均成本
近期的平均成本为15.39元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"15.39","date":1772352741,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，接近行业平均水平。
[{"date":"2026.03.02","stock":"-4.80","trade":null,"ind":"-0.20"},{"date":"2026.02.27","stock":"1.07","trade":null,"ind":"-0.06"},{"date":"2026.02.26","stock":"-1.06","trade":null,"ind":"0.19"},{"date":"2026.02.25","stock":"1.13","trade":null,"ind":"1.29"},{"date":"2026.02.24","stock":"1.41","trade":null,"ind":"1.36"},{"date":"2026.02.13","stock":"0.26","trade":null,"ind":"-1.28"},{"date":"2026.02.12","stock":"-0.38","trade":null,"ind":"0.86"},{"date":"2026.02.11","stock":"-0.89","trade":null,"ind":"-0.35"},{"date":"2026.02.10","stock":"0.25","trade":null,"ind":"0.02"},{"date":"2026.02.09","stock":"1.22","trade":null,"ind":"2.17"},{"date":"2026.02.06","stock":"0.19","trade":null,"ind":"-0.33"},{"date":"2026.02.05","stock":"-1.14","trade":null,"ind":"-1.44"},{"date":"2026.02.04","stock":"0.32","trade":null,"ind":"2.40"},{"date":"2026.02.02","stock":"-2.15","trade":null,"ind":"-2.69"},{"date":"2026.01.30","stock":"-2.28","trade":null,"ind":"-0.66"},{"date":"2026.01.29","stock":"0.25","trade":null,"ind":"-0.30"},{"date":"2026.01.28","stock":"-4.15","trade":null,"ind":"0.09"},{"date":"2026.01.27","stock":"-2.48","trade":null,"ind":"0.09"},{"date":"2026.01.26","stock":"0.82","trade":null,"ind":"-0.85"},{"date":"2026.01.23","stock":"2.88","trade":null,"ind":"0.79"},{"date":"2026.01.22","stock":false,"trade":null,"ind":"0.50"}]
冠昊生物,深证成指,医疗器械指数
压力支撑
该股压力位为15.39元，支撑位为15.03元。
[{"text":"\u538b\u529b\u4f4d","value":"15.39","date":1772380800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"15.03","date":1772380800,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.4资金面打败了31%的股票
主力控盘前10的股票
行业资金
医疗器械行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：03月02日 20:30
| 机构今日流向(万元) | -1796.71 | 机构5日流向(万元) | -2463.76 |
| 机构10日流向(万元) | -5868.86 | 机构20日流向(万元) | -16580.81 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量增加274.91万股，其中基金净减仓5家，主力净增仓16家，请投资者中长期谨慎为宜。
截止2025-06-30，共40家主力机构（基金34家，一般法人4家，QFII1家，信托公司1家），持仓量总计7846.9万股，占流通A股29.60%
其中，基金持仓与2024-12-31相比：
增仓：5家 ，增持 3.28万股
减仓：10家 ，减持 3.10万股
新出现在主力名单中：21家 ，持有2000.18万股
从主力名单中消失：5家 ，原持有16.97万股
其中，基金持仓与2024-12-31相比：
增仓：5家 ，增持 3.28万股
减仓：10家 ，减持 3.10万股
新出现在主力名单中：21家 ，持有2000.18万股
从主力名单中消失：5家 ，原持有16.97万股
消息面诊股
诊断结果：5消息面打败了39%的股票
今日有利好新闻的公司
近期该股消息很少，消息面信号较弱。
更多>>个股资讯
- 冠昊生物（截止2026年2月13日）股东人数为29
2026-02-25 - 国产脑机接口产业链，最硬核的15家公司
2026-02-12 - 冠昊生物（截止2026年1月30日）股东人数为30
2026-02-04 - 冠昊生物（截止2026年1月20日）股东人数为31
2026-01-23 - 公募加速布局医疗投资机会！规模最大的医疗设备ETF
2026-01-22 - 冠昊生物：公司暂未与强脑科技展开合作
2026-01-16 - 冠昊生物：公司生物型硬脑（脊）膜补片目前主要适用于
2026-01-16 - 冠昊生物：公司当前生产经营活动正常有序
2026-01-13 - 冠昊生物：公司目前未涉及脑机接口业务
2026-01-12 - 多地医院脑机接口专利公开，叠加技术突破利好，脑机接
2026-01-09
消息列表
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-28 |
| 一般消息 | 重大事项 | 关联交易 | 2025-07-01 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-06-23 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-06-07 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-05-27 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-04-23 |
| 一般消息 | 重大事项 | 关联交易 | 2025-04-23 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 0条 | 0条 | 0条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：3.5行业面打败了49%的股票
医疗器械行业最新资金流向
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
[{"date":"2026.03.02","price":"-0.20","value":null},{"date":"2026.02.27","price":"-0.06","value":null},{"date":"2026.02.26","price":"0.19","value":null},{"date":"2026.02.25","price":"1.29","value":null},{"date":"2026.02.24","price":"1.36","value":null},{"date":"2026.02.13","price":"-1.28","value":null},{"date":"2026.02.12","price":"0.86","value":null},{"date":"2026.02.11","price":"-0.35","value":null},{"date":"2026.02.10","price":"0.02","value":null},{"date":"2026.02.09","price":"2.17","value":null},{"date":"2026.02.06","price":"-0.33","value":null},{"date":"2026.02.05","price":"-1.44","value":null},{"date":"2026.02.04","price":"2.40","value":null},{"date":"2026.02.02","price":"-2.69","value":null},{"date":"2026.01.30","price":"-0.66","value":null},{"date":"2026.01.29","price":"-0.30","value":null},{"date":"2026.01.28","price":"0.09","value":null},{"date":"2026.01.27","price":"0.09","value":null},{"date":"2026.01.26","price":"-0.85","value":null},{"date":"2026.01.23","price":"0.79","value":null},{"date":"2026.01.22","price":"0.50","value":"-357279036.44"}]
深证成指,医疗器械行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 爱迪特 | 61.50% | 44.14% | 6.5分 |
| 2 | 振德医疗 | 26.91% | 4.53% | 6.6分 |
| 3 | 赛科希德 | 23.53% | 10.02% | 5.6分 |
| 4 | 九安医疗 | 15.22% | 18.43% | 6.1分 |
| 5 | 采纳股份 | 14.80% | 8.38% | 5.7分 |
| 6 | 天智航 | 14.67% | 9.78% | 5.5分 |
| 8 | 华强科技 | 10.21% | 9.85% | 6.1分 |
| 10 | 凯普生物 | 8.28% | -3.82% | 4.1分 |
| 12 | 英科医疗 | 3.69% | 14.26% | 5.8分 |
| 14 | 康拓医疗 | 2.32% | 2.98% | 5.8分 |
| 16 | 中源协和 | 1.06% | 10.32% | 5.4分 |
| 18 | 戴维医疗 | 0.85% | -0.49% | 5.5分 |
| 20 | 港通医疗 | 0.73% | -2.57% | 4.8分 |
| 22 | 英诺特 | 0.45% | 2.20% | 5.4分 |
| 24 | 五洲医疗 | 0.31% | 1.97% | 4.9分 |
| 26 | 西山科技 | -1.42% | -0.68% | 4.7分 |
| 28 | 惠泰医疗 | -1.60% | 2.67% | 5.3分 |
| 30 | 维力医疗 | -1.95% | -2.80% | 5.4分 |
| 32 | 正川股份 | -2.32% | -1.89% | 4.5分 |
| 34 | 奥精医疗 | -2.35% | 0.98% | 5.2分 |
| 36 | 康德莱 | -2.66% | -0.54% | 5.0分 |
| 38 | 天益医疗 | -2.75% | 2.75% | 4.9分 |
| 40 | 三友医疗 | -2.98% | -1.93% | 5.0分 |
| 42 | 迈克生物 | -3.04% | -1.88% | 3.9分 |
| 44 | 山外山 | -3.33% | -4.17% | 5.8分 |
| 46 | 东方海洋 | -3.39% | 1.33% | 5.1分 |
| 48 | 基蛋生物 | -3.54% | -2.88% | 4.6分 |
| 50 | 安图生物 | -4.13% | -1.13% | 4.8分 |
| 52 | 麦澜德 | -4.15% | -0.20% | 5.6分 |
| 54 | - | -4.41% | -2.18% | 分 |
| 56 | 威高血净 | -4.57% | -2.48% | 5.1分 |
| 58 | 威高骨科 | -4.69% | 3.64% | 5.6分 |
| 60 | 奥泰生物 | -4.75% | -1.51% | 4.9分 |
| 62 | 爱朋医疗 | -4.88% | -2.09% | 4.7分 |
| 64 | 迪瑞医疗 | -5.01% | -0.61% | 4.1分 |
| 66 | - | -5.04% | 1.83% | 分 |
| 68 | 天臣医疗 | -5.11% | -1.04% | 5.7分 |
| 70 | 爱博医疗 | -5.34% | 0.34% | 4.9分 |
| 72 | 健信超导 | -5.58% | 6.57% | 5.9分 |
| 74 | 理邦仪器 | -5.69% | 0.34% | 5.8分 |
| 76 | 力诺药包 | -5.79% | 1.91% | 4.2分 |
| 78 | 科美诊断 | -5.97% | 0.00% | 4.1分 |
| 80 | 健帆生物 | -6.48% | -2.22% | 4.4分 |
| 82 | 易瑞生物 | -6.52% | -3.37% | 4.7分 |
| 84 | 澳华内镜 | -6.64% | 1.16% | 4.3分 |
| 86 | 正海生物 | -6.86% | -1.81% | 3.8分 |
| 88 | 海尔生物 | -7.37% | -1.04% | 4.7分 |
| 90 | 万孚生物 | -7.61% | -1.59% | 3.7分 |
| 92 | 利德曼 | -7.67% | -2.42% | 4.3分 |
| 94 | - | -7.68% | -0.16% | 分 |
| 96 | 鱼跃医疗 | -7.75% | 0.16% | 5.3分 |
| 98 | 东方生物 | -7.76% | -4.99% | 4.2分 |
| 100 | 圣湘生物 | -8.28% | -4.19% | 4.7分 |
| 102 | 睿昂基因 | -8.93% | -4.60% | 4.0分 |
| 104 | 新华医疗 | -9.07% | 0.07% | 4.6分 |
| 106 | 万东医疗 | -9.47% | -4.31% | 4.3分 |
| 108 | 安杰思 | -9.56% | -4.20% | 4.4分 |
| 110 | 新产业 | -9.67% | -2.88% | 4.8分 |
| 112 | 超研股份 | -9.79% | -3.48% | 5.2分 |
| 114 | 九强生物 | -9.96% | -1.00% | 3.4分 |
| 116 | 透景生命 | -10.58% | -3.64% | 3.2分 |
| 118 | 南微医学 | -10.80% | -3.80% | 4.9分 |
| 120 | 冠昊生物 | -11.01% | -2.36% | 4.8分 |
| 122 | 华大智造 | -11.97% | -4.78% | 4.7分 |
| 124 | - | -12.62% | -3.37% | 分 |
| 126 | 安必平 | -13.52% | -5.71% | 3.8分 |
| 128 | 康为世纪 | -14.73% | -3.94% | 4.0分 |
| 130 | 康众医疗 | -15.10% | 4.42% | 4.5分 |
| 132 | 春立医疗 | -20.70% | -4.18% | 5.2分 |
| 134 | 福瑞医科 | -21.31% | -13.28% | 4.5分 |
| 136 | - | - | 2.61% | 分 |
| 138 | 北芯生命 | - | 2.08% | 4.5分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 安信证券 | 2012-09-04 | 增持 | 增持 |
| 长江证券 | 2012-09-02 | 增持 | - |
更多>>行业资讯
- 2012-09-13北京药监局通知全市停用8家企业中药饮片
- 2012-09-13澳洲股指周四收跌0.5% 医疗及消费股领跌
- 2012-09-13基层中医药服务能力将获提升
- 2012-09-132012中国医疗卫生产业发展论坛召开
- 2012-09-13医药行业：媒体称新版基药目录品种将扩至700个
- 2012-09-13陕西县级公立医院改革全面推开
- 2012-09-138月中山CPI 环比涨0.1%
- 2012-09-13中金公司：医药板块选股坚持“稳健业绩+成长空间预期
- 2012-09-13澳洲股指周四盘初跌0.5% 医疗及消费股领跌
- 2012-09-13感冒药“实名制”个人信息易“走光”？ 法国立法严管
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 60/244 ， 10/244。
[{"date":"2025-09-30","value":"4.79","vol":"2.98"},{"date":"2025-06-30","value":"3.68","vol":"2.34"},{"date":"2025-03-31","value":"2.70","vol":"1.16"},{"date":"2024-12-31","value":"5.16","vol":"0.56"},{"date":"2024-09-30","value":"5.22","vol":"4.64"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
4.79 | 3.68 | 2.70 | 5.16 | 5.22 |
| 行业(%) | 2.98 | 2.34 | 1.16 | 0.56 | 4.64 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"77.69","vol":"51.73"},{"date":"2025-06-30","value":"78.05","vol":"52.04"},{"date":"2025-03-31","value":"77.05","vol":"51.41"},{"date":"2024-12-31","value":"79.46","vol":"52.51"},{"date":"2024-09-30","value":"78.64","vol":"53.36"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
77.69 | 78.05 | 77.05 | 79.46 | 78.64 |
| 行业(%) | 51.73 | 52.04 | 51.41 | 52.51 | 53.36 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 41/244 ， 61/244。
[{"date":"2025-09-30","value":"5.52","vol":"0.24"},{"date":"2025-06-30","value":"5.89","vol":"-1.07"},{"date":"2025-03-31","value":"3.67","vol":"-0.10"},{"date":"2024-12-31","value":"-6.60","vol":"1.15"},{"date":"2024-09-30","value":"-9.97","vol":"0.77"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
5.52 | 5.89 | 3.67 | -6.60 | -9.97 |
| 行业(%) | 0.24 | -1.07 | -0.10 | 1.15 | 0.77 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"-4.02","vol":"-15.37"},{"date":"2025-06-30","value":"1.27","vol":"-18.14"},{"date":"2025-03-31","value":"3.30","vol":"-2.59"},{"date":"2024-12-31","value":"-11.57","vol":"-23.09"},{"date":"2024-09-30","value":"-32.55","vol":"-19.92"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-4.02 | 1.27 | 3.30 | -11.57 | -32.55 |
| 行业(%) | -15.37 | -18.14 | -2.59 | -23.09 | -19.92 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 23/244 ， 105/244。
[{"date":"2025-09-30","value":"0.38","vol":"0.25"},{"date":"2025-06-30","value":"0.26","vol":"0.17"},{"date":"2025-03-31","value":"0.12","vol":"0.08"},{"date":"2024-12-31","value":"0.53","vol":"0.36"},{"date":"2024-09-30","value":"0.39","vol":"0.26"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.38 | 0.26 | 0.12 | 0.53 | 0.39 |
| 行业(次) | 0.25 | 0.17 | 0.08 | 0.36 | 0.26 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.81","vol":"1.66"},{"date":"2025-06-30","value":"0.57","vol":"1.12"},{"date":"2025-03-31","value":"0.29","vol":"0.55"},{"date":"2024-12-31","value":"1.03","vol":"2.32"},{"date":"2024-09-30","value":"0.81","vol":"1.64"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.81 | 0.57 | 0.29 | 1.03 | 0.81 |
| 行业(次) | 1.66 | 1.12 | 0.55 | 2.32 | 1.64 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"14.42","vol":"14.75"},{"date":"2025-06-30","value":"22.82","vol":"15.16"},{"date":"2025-03-31","value":"15.90","vol":"4.21"},{"date":"2024-12-31","value":"17.33","vol":"29.34"},{"date":"2024-09-30","value":"-2.76","vol":"15.46"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 14.42 | 22.82 | 15.90 | 17.33 | -2.76 |
| 行业 | 14.75 | 15.16 | 4.21 | 29.34 | 15.46 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.01"},{"date":"2025-06-30","value":"1.86","vol":"1.57"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"2.73","vol":"2.17"},{"date":"2024-09-30","value":"","vol":"0.01"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 1.86 | - | 2.73 | - |
| 行业 | 0.01 | 1.57 | 0.00 | 2.17 | 0.01 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 3/244 ， 17/244。
[{"date":"2025-09-30","value":"1.97","vol":"5.66"},{"date":"2025-06-30","value":"1.85","vol":"5.47"},{"date":"2025-03-31","value":"1.94","vol":"5.84"},{"date":"2024-12-31","value":"1.49","vol":"5.30"},{"date":"2024-09-30","value":"1.67","vol":"5.83"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
1.97 | 1.85 | 1.94 | 1.49 | 1.67 |
| 行业 | 5.66 | 5.47 | 5.84 | 5.30 | 5.83 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"1.25","vol":"4.51"},{"date":"2025-06-30","value":"1.25","vol":"4.35"},{"date":"2025-03-31","value":"1.25","vol":"4.73"},{"date":"2024-12-31","value":"0.95","vol":"4.27"},{"date":"2024-09-30","value":"1.07","vol":"4.70"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
1.25 | 1.25 | 1.25 | 0.95 | 1.07 |
| 行业 | 4.51 | 4.35 | 4.73 | 4.27 | 4.70 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 19/244 ， 24/244。
[{"date":"2025-09-30","value":"36.28","vol":"22.07"},{"date":"2025-06-30","value":"37.41","vol":"22.01"},{"date":"2025-03-31","value":"36.10","vol":"21.19"},{"date":"2024-12-31","value":"38.02","vol":"21.94"},{"date":"2024-09-30","value":"35.50","vol":"20.60"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
36.28 | 37.41 | 36.10 | 38.02 | 35.50 |
| 行业(%) | 22.07 | 22.01 | 21.19 | 21.94 | 20.60 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.49","vol":"0.71"},{"date":"2025-06-30","value":"0.52","vol":"0.58"},{"date":"2025-03-31","value":"0.50","vol":"0.56"},{"date":"2024-12-31","value":"0.53","vol":"0.55"},{"date":"2024-09-30","value":"0.47","vol":"0.37"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.49 | 0.52 | 0.50 | 0.53 | 0.47 |
| 行业(%) | 0.71 | 0.58 | 0.56 | 0.55 | 0.37 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2025年的收益，请投资者后续关注。
[{"date":"2021","yellowRectValue":"0.74","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"-3.08","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.31","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"0.27","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]